| Primary |
| Headache |
20.5% |
| Arthritis |
12.8% |
| Product Used For Unknown Indication |
12.6% |
| Back Pain |
10.3% |
| Pain |
9.3% |
| Analgesic Therapy |
7.0% |
| Toothache |
4.1% |
| Dysmenorrhoea |
3.6% |
| Pain Relief |
3.2% |
| Back Ache |
3.1% |
| Arthralgia |
2.7% |
| Ischaemic Heart Disease Prophylaxis |
2.0% |
| Pain In Extremity |
1.9% |
| Myalgia |
1.4% |
| Pain Nos |
1.2% |
| Neck Pain |
1.1% |
| Myocardial Infarct Prophylaxis |
0.9% |
| Migraine |
0.8% |
| General Body Pain |
0.8% |
| Musculoskeletal Pain |
0.8% |
|
| Drug Ineffective |
41.0% |
| Overdose |
9.1% |
| Headache |
7.6% |
| No Adverse Event |
7.3% |
| Incorrect Drug Administration Duration |
7.2% |
| Pain |
5.3% |
| Back Pain |
3.4% |
| Therapeutic Response Unexpected |
2.6% |
| Nausea |
2.0% |
| Urticaria |
1.8% |
| Somnolence |
1.6% |
| Migraine |
1.5% |
| Vomiting |
1.4% |
| Off Label Use |
1.3% |
| Dysmenorrhoea |
1.3% |
| Inappropriate Schedule Of Drug Administration |
1.2% |
| Arthritis |
1.2% |
| Incorrect Dose Administered |
1.1% |
| Insomnia |
1.1% |
| Arthralgia |
1.0% |
|
| Secondary |
| Arthritis |
21.3% |
| Pain |
10.9% |
| Headache |
10.4% |
| Back Pain |
8.6% |
| Analgesic Therapy |
6.3% |
| Product Used For Unknown Indication |
5.4% |
| Myalgia |
3.9% |
| Pain Relief |
3.9% |
| Arthralgia |
3.6% |
| Dysmenorrhoea |
3.6% |
| Back Ache |
3.4% |
| Toothache |
3.2% |
| Neck Pain |
2.9% |
| Pain In Extremity |
2.0% |
| Ear Pain |
1.8% |
| Migraine |
1.8% |
| Pain Ankle |
1.8% |
| Painful Feet |
1.8% |
| Rheumatoid Arthritis |
1.8% |
| Menstrual Cramp |
1.4% |
|
| Drug Ineffective |
26.2% |
| Overdose |
15.5% |
| Incorrect Drug Administration Duration |
10.7% |
| Headache |
6.4% |
| Pain |
5.9% |
| No Adverse Event |
5.3% |
| Off Label Use |
4.8% |
| Therapeutic Response Unexpected |
3.2% |
| Arthritis |
2.7% |
| Vomiting |
2.7% |
| Inappropriate Schedule Of Drug Administration |
2.1% |
| Incorrect Dose Administered |
2.1% |
| Toothache |
2.1% |
| Urticaria |
2.1% |
| Nausea |
1.6% |
| Pruritus |
1.6% |
| Stomatitis |
1.6% |
| Abdominal Discomfort |
1.1% |
| Abdominal Pain Upper |
1.1% |
| Arthralgia |
1.1% |
|
| Concomitant |
| Multiple Sclerosis |
46.2% |
| Supplementation Therapy |
15.4% |
| Ischaemic Heart Disease Prophylaxis |
7.7% |
| Oral Contraception |
7.7% |
| Premenstrual Dysphoric Disorder |
7.7% |
| Premenstrual Syndrome |
7.7% |
| Relapsing-remitting Multiple Sclerosis |
7.7% |
|
| Cholecystitis Chronic |
11.1% |
| Haemorrhage Subcutaneous |
11.1% |
| Injection Site Reaction |
11.1% |
| Muscle Spasms |
11.1% |
| Musculoskeletal Stiffness |
11.1% |
| Myalgia |
11.1% |
| Pain |
11.1% |
| Treatment Noncompliance |
11.1% |
| Vomiting |
11.1% |
|
